Flownium provides an on‑premise AI governance platform for pharmaceutical manufacturers and CROs, embedding AI execution within versioned, approved workflows to meet GxP compliance.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical companies face strict GxP regulations that make it difficult to adopt AI technologies, as existing AI tools often lack auditability, version control, and integration with legacy quality and data management systems.
Solution
Flownium offers an on‑premise AI governance platform that embeds AI execution within versioned, approved workflows. The platform visually designs and configures regulated workflows, integrates data from existing QMS, ERP, LIMS, and EDMS systems without requiring replacements, and enforces configurable business rules. Each AI decision is captured with full traceability, role‑based validations, and audit‑ready documentation, ensuring compliance with GxP standards. By keeping all processing within the customer’s infrastructure, Flownium eliminates cloud‑related security concerns while providing a governed framework for AI‑driven process acceleration.
Target Audience
Primary customers are pharmaceutical manufacturers and contract research organizations that need to incorporate AI into regulated GxP processes while maintaining compliance and data security.
Features
- Visual, drag‑and‑drop workflow designer with configurable business rules
- Seamless orchestration of data from QMS, ERP, LIMS, and EDMS systems
- On‑premise deployment ensuring data never leaves the client’s infrastructure
- Versioned workflow management with role‑based approvals and validations
- Automatic generation of audit‑ready logs for every AI decision
- Governance layer that restricts AI actions to validated workflow contexts